CytoSorbents Announces New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor and Updates Recent DrugSorb-ATR FDA Pre-Submission Meetings

Stock Information for Reviva Pharmaceuticals Holdings Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Reviva Pharmaceuticals Holdings Inc.

CytoSorbents to Present at the H.C. Wainwright 28th Annual Global Investment Conference
CytoSorbents Announces Reverse Stock Split
CytoSorbents Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update
CytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business Highlights
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
CytoSorbents to Present at the Life Sciences Forum on June 24, 2026 and Meet Virtually with Investors on June 30, 2026
CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.